Inhaled drug reduces lung damage by targeting overactive immune cells
Researchers have developed an inhalable RNA-based drug that targets the overactive white blood cells that cause lung damage during severe infection, reducing inflammation and scarring. With human clinical trials expected next year, the drug may soon be… Continue reading Inhaled drug reduces lung damage by targeting overactive immune cells